156 related articles for article (PubMed ID: 36073766)
1. The long non-coding RNA PANDAR regulates cell proliferation and epithelial-to-mesenchymal transition in glioma.
Guo J; Xiao D; Lin Z; Sui C
Histol Histopathol; 2023 Feb; 38(2):199-208. PubMed ID: 36073766
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of long noncoding RNA zinc finger antisense 1 enhances epithelial-mesenchymal transition in vitro and predicts poor prognosis in glioma.
Lv QL; Chen SH; Zhang X; Sun B; Hu L; Qu Q; Huang YT; Wang GH; Liu YL; Zhang YY; Zhou HH
Tumour Biol; 2017 Mar; 39(3):1010428317695022. PubMed ID: 28349823
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancer.
Li Y; Su X; Pan H
Cancer Biomark; 2019; 25(2):185-192. PubMed ID: 31104011
[TBL] [Abstract][Full Text] [Related]
4. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
5. Expression of long non-coding RNA PANDAR and its prognostic value in colorectal cancer patients.
Li X; Wang F; Sun Y; Fan Q; Cui G
Int J Biol Markers; 2017 May; 32(2):e218-e223. PubMed ID: 28106228
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.
Zhan Y; Lin J; Liu Y; Chen M; Chen X; Zhuang C; Liu L; Xu W; Chen Z; He A; Zhang Q; Sun X; Zhao G; Huang W
J Exp Clin Cancer Res; 2016 May; 35(1):83. PubMed ID: 27206339
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
8. An increase in long non-coding RNA PANDAR is associated with poor prognosis in clear cell renal cell carcinoma.
Xu Y; Tong Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Xie L
BMC Cancer; 2017 May; 17(1):373. PubMed ID: 28545465
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of long non-coding RNA BLACAT1 predicts aggressive clinicopathologic characteristics and poor prognosis of glioma.
Zhang X; Wei X; Liu J; Yang J; Jin P
Medicine (Baltimore); 2021 Mar; 100(11):e20722. PubMed ID: 33725920
[TBL] [Abstract][Full Text] [Related]
10. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
Jiang Y; Feng E; Sun L; Jin W; You Y; Yao Y; Xu Y
Biomed Pharmacother; 2017 Nov; 95():685-691. PubMed ID: 28886528
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA SNHG6 promotes glioma tumorigenesis by sponging miR-101-3p.
Meng Q; Yang BY; Liu B; Yang JX; Sun Y
Int J Biol Markers; 2018 May; 33(2):148-155. PubMed ID: 29799357
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer.
Liu J; Ben Q; Lu E; He X; Yang X; Ma J; Zhang W; Wang Z; Liu T; Zhang J; Wang H
Cell Death Dis; 2018 Feb; 9(2):168. PubMed ID: 29416011
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition.
Liu H; Lv Z; Guo E
Int J Clin Exp Pathol; 2015; 8(8):9140-6. PubMed ID: 26464658
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of Long Noncoding RNA CCAT2 Inhibits Cellular Proliferation, Invasion, and Epithelial-Mesenchymal Transition in Glioma Cells.
Zeng J; Du T; Song Y; Gao Y; Li F; Wu R; Chen Y; Li W; Zhou H; Yang Y; Pei Z
Oncol Res; 2017 Jul; 25(6):913-921. PubMed ID: 27938499
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of LncRNA PANDAR predicts poor prognosis and promotes cell proliferation in cervical cancer.
Huang HW; Xie H; Ma X; Zhao F; Gao Y
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4529-4535. PubMed ID: 29131264
[TBL] [Abstract][Full Text] [Related]
16. The prognostic and therapeutic values of long noncoding RNA PANDAR in colorectal cancer.
Rivandi M; Pasdar A; Hamzezadeh L; Tajbakhsh A; Seifi S; Moetamani-Ahmadi M; Ferns GA; Avan A
J Cell Physiol; 2019 Feb; 234(2):1230-1236. PubMed ID: 30191971
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
Peng W; Fan H
Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
[TBL] [Abstract][Full Text] [Related]
18. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding PANDAR as a novel biomarker in human cancer: A systematic review.
Zou Y; Zhong Y; Wu J; Xiao H; Zhang X; Liao X; Li J; Mao X; Liu Y; Zhang F
Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29226461
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA CASC15 regulates gastric cancer cell proliferation, migration and epithelial mesenchymal transition by targeting CDKN1A and ZEB1.
Wu Q; Xiang S; Ma J; Hui P; Wang T; Meng W; Shi M; Wang Y
Mol Oncol; 2018 Jun; 12(6):799-813. PubMed ID: 29489064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
